Recommends To The Government The Adoption Of Measures For Generic Consumption Expansion And Reducing The Waste Of Prescription Drugs And Diagnostic And Therapeutic Guidelines

Original Language Title: Recomenda ao Governo a adopção de medidas de expansão do consumo de genéricos e de redução do desperdício de medicamentos prescritos e de orientações em diagnóstico e terapêutica

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now

Read the untranslated law here: http://app.parlamento.pt/webutils/docs/doc.pdf?path=6148523063446f764c3246795a5868774d546f334e7a67774c336470626d6c7561574e7059585270646d467a4c316776644756346447397a4c334271636a45794e7931594c6d527659773d3d&fich=pjr127-X.doc&Inline=false

1 DRAFT RESOLUTION N° 127/X/"Recommends to the Government the adoption of measures for generic consumption expansion and reducing the waste of prescription drugs and diagnostic and therapeutic guidelines."

Health, considered as good and essential law of citizens, have in medicine a fundamental pillar for the improvement of the levels of quality of life, which is a vector of economic development and scientific progress. In the field of health, the national indicators show a remarkable progression of our country, in recent decades, particularly in terms of life expectancy, putting us close to the European average, which must be credited to the national health service, and the health system, in particular to your organisation, the professionals, the pharmaceutical industry and to the network of pharmacies , with outlets throughout the whole country. The special nature of the right which is the health benefit of the extraordinary contribution scientific advances and technological advances in medicine, has long determining an unstoppable demand for new care, both in terms of equipment, such as treatments, as well as new drugs. This process has, of course, as a reflex, a strong impulse to the level of investment in research, with obvious and important subsequent repercussions on industrial production and trade. Governments have come to recognize and assume the strategic nature of pharmaceutical research and production, national approving measures to promote the sector, supporting research, and strategies of conquest of dimension, notably through international cooperation 2. But, the progressive increase of the expenditure in the area of health, in particular with medicines, there are very determined measures of rationality and balance, even in the most developed countries of the European Union. In Portugal, the total expenditure on health represent about 9.6 percent of GDP, a percentage higher than the observed in many countries of the Union, whilst being illustrative, for example, the fact that in 1970, in our country, the actual spending with health as% of GDP, significantly lower than those of Spain and the United Kingdom, while in recent years , this relationship was reversed so prominent, to the detriment of our country; or the case of Sweden, there are 15 years spent, in% of GDP, more than Portugal with their health expenses, for, at present, present indicators of total expenditure lower than our country. One other data referenced to 2001, and related to the national consumption of drugs in the outpatient clinic, per capita, indicated this exceeded in absolute value spending per capita in the United Kingdom, a country that integrates the Group of most developed countries of the European Union. However, a recent study shows that 49.7 percent of prescription drugs are wasted, i.e. almost half of medicinal prescriptions are not used, which confirms a reality long perceived by health professionals, but until then never quantified. This situation will, according to the study, the suspension of medication by the sick and the mismatch between the size of the packaging and the duration of treatment. How to refer to the authors of the study, and it seems clear, this situation constitutes great risks to public health, for the non-completion of therapy, the risk of creating resistance, but also the possibility of self-medication with drugs eventually later expired and, therefore, potentially toxic. One such reality demonstrates, satiety, so absolutely dramatic, it's a colossal waste of economic resources. If we're still present that about half of the medicines consumed is imported, we can assess the impact on the national economy from the negative effects of the lack of rationality in this area of health. 3 the resizing of packaging has been the subject of some attention by the authorities responsible in several Governments, but the practical consequence, several groups of us pharmaceuticals, was solid and persistent imbalance. Also take into account the undeniable data published by "Portuguese Health systems Observatory" in their reporting of the spring of 2004 and 2005, and a comprehensive study the 26 countries of Europe, published in the journal "Lancet" in 2005, confirming indicators concern about Portuguese profile of drug consumption, some therapeutic groups, like antibiotics for example in clear disagreement with the scientific recommendations of the international organizations of reference in the field of medicine, with economic and public health consequences harmful to our country. To highlight the fact that, despite the interesting and continuous growth of the generic market for some time now, these represent approximately 14% of the total value of sales of medicines in our country, in euros, while the volume of units sold compared with the total market if encrypt only on 10%. This sets some distortion of the principles guiding the role of generics on the market, and requires the taking of measures to deploy the generics in your relative importance value/volume, in line with the majority of countries with all the success the implant on the market. Thus becomes clear, the State, its citizens, or both, spend on medicines more than is reasonable and in line with the average health care level required in a modern society, with the level of development and the possibilities of the country. Is still sense by the professionals, the diagnostic and therapeutic level, any lack of up-to-date information and systematized, according to DG Health standards and good practice, which contributes to some dispersion on the criteria used in clinical exercise, potentially damaging to the defense of professionals before any litigation with the users of the system. All this has contributed to a health system with some elements of despesismo and dysfunctionality, incorporating unnecessary tensions for reasons that have nothing to do with the progress of the system, decreasing public confidence, and nurturing the idea of predominance of corporate interests over the interests of the citizens. 4 Remembered and highlighted the important national developments in healthcare, and recognized the key actors the righteous merits of this evolution, it is quite clear, urgent and imperative, the need for rationality and balance in this area. The framework described may change in the best sense. The change is within reach of the same agents and entities that contributed to a very positive developments in the country over the past few decades, because: 1 there is among the most developed countries of the European Union quotas of generic drug consumption in the order of 40-50%. And such drugs can be obtained 35% cheaper than the originals. Portugal is far from this reality and it is desirable that the State create conditions to reverse the current state of things, safeguarding that generic drugs are actually cheaper than the branded. 2 according to experts in the sector, about half of existing active substances in the Portuguese market no longer have patent rights and may become generic. The domestic industry may have on the strengthening of the domestic market of generics a means of your own pivot and search skills and competitive ability in the international market, in particular through cooperation. 3 studies show that over the past two years, 46.7% of prescription drugs could have been replaced by generics, on the part of doctors. It is essential that the State mobilize and interested health professionals to this national design that everyone can benefit. 4 the recent Protocol between the Ministry of health and the Pharmaceutical Industry may come to constitute a new opportunity for rationalisation of the pharmaceutical market, and development of scientific research in new molecules and new projects of internationalization based on technological innovation. 5 State, health professionals, industry, pharmacy, can ensure the prescription, supply and dispensing of medications in doses appropriate for each therapy, avoiding the colossal waste that today. 6 the external economy of the country will be highly benefited by a policy of 5 medicine that promotes the increased consumption of generics and a reduction of waste of prescription drugs, whether generic or branded.

Aware of this subject, interpreting and defending the interests of the citizens, and overcoming ideological differences and partisan, the Assembly of the Republic can point a way through a clear message of confidence in the possibility of creating a framework of solutions that must be naturally required for each agent, but at the same time take into consideration their even-handed expectations , integrated into a streamlined, Portuguese market without creating constraints in terms of sustainability. Such a framework to be developed by the Government, must ensure the agreement and a broad participation of agents of the sector, but it cannot be blocked by resistance from corporate interests, contrary to the greater interest of the Portuguese. With regard to the recitals, the Parliament decides, in accordance with the provisions of subparagraph (b)) of article 156 of the Constitution of the Portuguese Republic, recommend to the Government the following: I – to develop a program that ensures the growth of generic market, comparable to checked in the most developed countries in this area, and even mechanisms that their prices are actually lower than those of mark. II – to promote the consolidation of the activity and competitiveness of the pharmaceutical industry, in particular in the field of generics. III – to develop studies in order to create the single dose in the pantry and marketing of medicines throughout the clinic. IV – To encourage the functional units of S.N.S. (Family Health Units, health centres, emergency services, outpatient Hospital Services, etc.) the prescription of generic drugs, according to the national objectives. V – to adopt, in collaboration with the professional organisations of the sector (specialty colleges of the order of doctors, medical associations, foundations, medical societies, order of pharmacists), a Manual or guide of good practices in diagnostic and therapeutic tests 6 ", Advisor and facilitator of professional practice, in order to make converge the clinical diagnostic and therapeutic activities according to good clinical practice of international consensus and the current state of the art.

Palácio de s. bento, 11 May 2006 Members of the Socialist Party